Kips Bay Medical, which offers vein support technology used in coronary artery bypass surgery, will see its quiet period end on Tuesday, March 22. On February 10, the company raised $16.5 million by offering 2.1 million shares at $8, at the low end of the range of $8 to $1. Rodman & Renshaw and Newbridge Securities acted as lead managers on the deal.
